You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 5, May 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Neurological Review
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (53)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Nutritional and Metabolic Disorders
 •Lipids and Lipid Disorders
 •Alert me on articles by topic

Role of the Low-density Lipoprotein Receptor–Related Protein in {beta}-Amyloid Metabolism and Alzheimer Disease

Bradley T. Hyman, MD, PhD; Dudley Strickland, PhD; G. William Rebeck, PhD

Arch Neurol. 2000;57:646-650.

Deposition of {beta}-amyloid (A{beta}), a metabolite of approximately 4 kd of the amyloid precursor protein, is a critical pathological feature in Alzheimer disease. We postulate that deposition reflects an imbalance of A{beta} synthesis and clearance. Several pathways that impact A{beta} converge on a single receptor molecule, the low-density lipoprotein receptor–related protein (LRP). This multifunctional receptor is the major neuronal receptor both for apolipoprotein E (apoE, protein; APOE, gene) and for {alpha}2-macroglobulin ({alpha}2M, protein; A2M, gene), and it mediates clearance of apoE/A{beta} and {alpha}2M/A{beta} complexes. The LRP also interacts with the amyloid precursor protein itself. In this review, we highlight data that support a role for LRP in A{beta} metabolism and hypothesize that LRP therefore plays a critical role in Alzheimer disease.


From the Alzheimer Disease Research Laboratory, Massachusetts General Hospital, Boston (Drs Hyman and Rebeck), and The Holland Laboratory, American Red Cross, Rockville, Md (Dr Strickland).


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(5):762-763.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Green Banana*: Dementia Epidemiology Research: It Is Time to Modify the Focus of Research
Kuller
J. Gerontol. A Biol. Sci. Med. Sci. 2006;61:1314-1318.
ABSTRACT | FULL TEXT  

Differential modulation of plasma {beta}-amyloid by insulin in patients with Alzheimer disease
Kulstad et al.
Neurology 2006;66:1506-1510.
ABSTRACT | FULL TEXT  

Functional Candidate Genes in Age-Related Macular Degeneration: Significant Association with VEGF, VLDLR, and LRP6
Haines et al.
IOVS 2006;47:329-335.
ABSTRACT | FULL TEXT  

Energy Inhibition Elevates {beta}-Secretase Levels and Activity and Is Potentially Amyloidogenic in APP Transgenic Mice: Possible Early Events in Alzheimer's Disease Pathogenesis
Velliquette et al.
J. Neurosci. 2005;25:10874-10883.
ABSTRACT | FULL TEXT  

Plasma Total Cholesterol Level as a Risk Factor for Alzheimer Disease: The Framingham Study
Tan et al.
Arch Intern Med 2003;163:1053-1057.
ABSTRACT | FULL TEXT  

Internalization of {beta}-Amyloid Causes Downregulation of Apolipoprotein E mRNA Expression in Neuroblastoma Cells
Yamauchi et al.
Annals of Clinical & Laboratory Science 2003;33:68-78.
ABSTRACT | FULL TEXT  

Proteasome Regulates the Delivery of LDL Receptor-related Protein into the Degradation Pathway
Melman et al.
Mol. Biol. Cell 2002;13:3325-3335.
ABSTRACT | FULL TEXT  

The Impact of the Use of Statins on the Prevalence of Dementia and the Progression of Cognitive Impairment
Hajjar et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2002;57:M414-418.
ABSTRACT | FULL TEXT  

Distinct Binding Sites in the Structure of alpha 2-Macroglobulin Mediate the Interaction with beta -Amyloid Peptide and Growth Factors
Mettenburg et al.
J. Biol. Chem. 2002;277:13338-13345.
ABSTRACT | FULL TEXT  

The molecular and genetic basis of AD: The end of the beginning: The 2000 Wartenberg lecture
Rosenberg
Neurology 2000;54:2045-2054.
FULL TEXT  

Serine Proteinase Inhibitor 3 and Murinoglobulin I Are Potent Inhibitors of Neuropsin in Adult Mouse Brain
Kato et al.
J. Biol. Chem. 2001;276:14562-14571.
ABSTRACT | FULL TEXT  

The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors
Bacskai et al.
Proc. Natl. Acad. Sci. USA 2000;97:11551-11556.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.